Gossamer Bio Statistics

Total Valuation

Gossamer Bio has a market cap or net worth of $80.95 million. The enterprise value is $146.92 million.

Market Cap	80.95M
Enterprise Value	146.92M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Gossamer Bio has 234.70 million shares outstanding. The number of shares has increased by 1.01% in one year.

Current Share Class	234.70M
Shares Outstanding	234.70M
Shares Change (YoY)	+1.01%
Shares Change (QoQ)	-0.60%
Owned by Insiders (%)	3.58%
Owned by Institutions (%)	67.15%
Float	211.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.67
Forward PS	4.50
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.64

Current Ratio	2.64
Quick Ratio	2.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14.86

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-41.86%
Return on Invested Capital (ROIC)	-65.30%
Return on Capital Employed (ROCE)	-150.03%
Weighted Average Cost of Capital (WACC)	7.66%
Revenue Per Employee	$299,204
Profits Per Employee	-$1.05M
Employee Count	162
Asset Turnover	0.20
Inventory Turnover	n/a

Taxes

Income Tax	-88,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.01% in the last 52 weeks. The beta is 2.16, so Gossamer Bio's price volatility has been higher than the market average.

Beta (5Y)	2.16
52-Week Price Change	-64.01%
50-Day Moving Average	0.55
200-Day Moving Average	2.08
Relative Strength Index (RSI)	33.68
Average Volume (20 Days)	7,039,922

Short Selling Information

The latest short interest is 40.20 million, so 17.13% of the outstanding shares have been sold short.

Short Interest	40.20M
Short Previous Month	37.50M
Short % of Shares Out	17.13%
Short % of Float	19.04%
Short Ratio (days to cover)	3.56

Income Statement

In the last 12 months, Gossamer Bio had revenue of $48.47 million and -$170.37 million in losses. Loss per share was -$0.75.

Revenue	48.47M
Gross Profit	48.47M
Operating Income	-163.25M
Pretax Income	-170.46M
Net Income	-170.37M
EBITDA	-163.23M
EBIT	-163.25M
Loss Per Share	-$0.75

Full Income Statement

Balance Sheet

The company has $136.93 million in cash and $202.91 million in debt, giving a net cash position of -$65.97 million or -$0.28 per share.

Cash & Cash Equivalents	136.93M
Total Debt	202.91M
Net Cash	-65.97M
Net Cash Per Share	-$0.28
Equity (Book Value)	-122.76M
Book Value Per Share	-0.53
Working Capital	104.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$171.27 million and capital expenditures -$79,000, giving a free cash flow of -$171.35 million.

Operating Cash Flow	-171.27M
Capital Expenditures	-79,000
Depreciation & Amortization	24,000
Net Borrowing	n/a
Free Cash Flow	-171.35M
FCF Per Share	-$0.73

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-336.81%
Pretax Margin	-351.67%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Gossamer Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.01%
Shareholder Yield	-1.01%
Earnings Yield	-210.47%
FCF Yield	-211.68%

Analyst Forecast

The average price target for Gossamer Bio is $4.19, which is 1,114.85% higher than the current price. The consensus rating is "Buy".

Price Target	$4.19
Price Target Difference	1,114.85%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	38.80%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gossamer Bio has an Altman Z-Score of -12.96. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-12.96
Piotroski F-Score	n/a